Synjardy XR 5 mg/1

Synjardy XR 5 mg/1 combines empagliflozin and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control when used as directed.

Synjardy XR 5 mg/1 is designed to help manage type 2 diabetes by improving blood sugar levels. It is often used when diet and exercise alone are not sufficient. This medication works by combining two active ingredients, empagliflozin and metformin hydrochloride, to support glucose regulation. People may ask, 'What is Synjardy XR used for?' primarily in the context of type 2 diabetes management.

Common effects of Synjardy XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or low blood sugar levels. These effects can vary among individuals and typically subside as the body adjusts to the medication.

Synjardy XR 5 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is important to stay hydrated and monitor blood sugar levels regularly. Always follow the advice of a healthcare provider regarding the use of this medication. Proper storage and adherence to prescribed guidelines are essential for safe use.

Synjardy XR 5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes treatments. Alcohol consumption should be avoided as it can increase the risk of low blood sugar. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.